Cite
Investigators at University for Health Sciences Discuss Findings in Diabetes Insipidus (Can Diabetes Insipidus Be Used As a Marker for Multisystemic and Progressive Disease In Langerhans Cell Histiocytosis?)
MLA
“Investigators at University for Health Sciences Discuss Findings in Diabetes Insipidus (Can Diabetes Insipidus Be Used As a Marker for Multisystemic and Progressive Disease In Langerhans Cell Histiocytosis?).” Women’s Health Weekly, Mar. 2022, p. 125. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.695855241&authtype=sso&custid=ns315887.
APA
Investigators at University for Health Sciences Discuss Findings in Diabetes Insipidus (Can Diabetes Insipidus Be Used As a Marker for Multisystemic and Progressive Disease In Langerhans Cell Histiocytosis?). (2022, March 10). Women’s Health Weekly, 125.
Chicago
Women’s Health Weekly. 2022. “Investigators at University for Health Sciences Discuss Findings in Diabetes Insipidus (Can Diabetes Insipidus Be Used As a Marker for Multisystemic and Progressive Disease In Langerhans Cell Histiocytosis?),” March 10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.695855241&authtype=sso&custid=ns315887.